Medizinische Klinik III Klinikum der Universität München-Großhadern

München 81377

0 studies enrolling now · 3 studies all time

What they study most

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes

Studies at this site

• Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes — Completed
• A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed